Alamar Biosciences, Inc. (ALMR) Options Greeks

Options Greeks measure sensitivity to various factors: Delta (price), Gamma (delta change), Theta (time decay), and Vega (volatility). They are essential for risk management and position sizing.

Alamar Biosciences, Inc. (ALMR) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.13B, listed on NASDAQ, employing roughly 222 people, carrying a beta of -6.18 to the broader market. Alamar Biosciences operates as a commercial-stage proteomics firm, specializing in the highly sensitive, simultaneous identification of various proteins for both scientific research and prospective medical applications. Led by Yuling Luo, public since 2026-04-17.

Options Greeks analysis provides sensitivity measures for price, time, and volatility. No recent options activity for ALMR as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how options Greeks is reported and how to read the data →